Last 12 months
Inside the activity.
0 purchase rows · 74 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 7 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 10, 2024 Filed Dec 11, 2024 17:50 UTC |
Samath JamieCFO and Head of Business Techn
|
SaleCommon Stock | 135 | $540.16 | $72,920.93 |
DisclosureSEC source: 0001035267-24-000277 · edgardoc.xml · nonDerivative · entry 4 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,757 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 17:50 UTC |
Samath JamieCFO and Head of Business Techn
|
Exercise / conversionCommon Stock | 135 | $229.39 | $30,967.65 |
DisclosureSEC source: 0001035267-24-000277 · edgardoc.xml · nonDerivative · entry 3 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 17:50 UTC |
Samath JamieCFO and Head of Business Techn
|
SaleCommon Stock | 135 | $540.16 | $72,920.93 |
DisclosureSEC source: 0001035267-24-000277 · edgardoc.xml · nonDerivative · entry 2 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,757 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 17:50 UTC |
Samath JamieCFO and Head of Business Techn
|
Exercise / conversionCommon Stock | 135 | $304.67 | $41,130.45 |
DisclosureSEC source: 0001035267-24-000277 · edgardoc.xml · nonDerivative · entry 1 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:35 UTC |
Samath JamieCFO and Head of Business Techn
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 94 | $0.00 Strike: $290.33 | $0.00 |
DisclosureSEC source: 0001035267-24-000273 · edgardoc.xml · derivative · entry 6 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,410 Underlying: Common Stock · 94 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:35 UTC |
Samath JamieCFO and Head of Business Techn
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 94 | $0.00 Strike: $208.90 | $0.00 |
DisclosureSEC source: 0001035267-24-000273 · edgardoc.xml · derivative · entry 5 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,410 Underlying: Common Stock · 94 shares Expires 2029-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:35 UTC |
Samath JamieCFO and Head of Business Techn
|
SaleCommon Stock | 94 | $539.00 | $50,666.00 |
DisclosureSEC source: 0001035267-24-000273 · edgardoc.xml · nonDerivative · entry 4 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,757 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:35 UTC |
Samath JamieCFO and Head of Business Techn
|
Exercise / conversionCommon Stock | 94 | $208.90 | $19,636.60 |
DisclosureSEC source: 0001035267-24-000273 · edgardoc.xml · nonDerivative · entry 3 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:35 UTC |
Samath JamieCFO and Head of Business Techn
|
SaleCommon Stock | 94 | $539.00 | $50,666.00 |
DisclosureSEC source: 0001035267-24-000273 · edgardoc.xml · nonDerivative · entry 2 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,757 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:35 UTC |
Samath JamieCFO and Head of Business Techn
|
Exercise / conversionCommon Stock | 94 | $290.33 | $27,291.02 |
DisclosureSEC source: 0001035267-24-000273 · edgardoc.xml · nonDerivative · entry 1 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:48 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 188 | $0.00 Strike: $290.33 | $0.00 |
DisclosureSEC source: 0001035267-24-000275 · edgardoc.xml · derivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,820 Underlying: Common Stock · 188 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:48 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 188 | $0.00 Strike: $208.90 | $0.00 |
DisclosureSEC source: 0001035267-24-000275 · edgardoc.xml · derivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,820 Underlying: Common Stock · 188 shares Expires 2029-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:48 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 188 | $539.00 | $101,332.00 |
DisclosureSEC source: 0001035267-24-000275 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,506 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:48 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 188 | $208.90 | $39,273.20 |
DisclosureSEC source: 0001035267-24-000275 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:48 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 188 | $539.00 | $101,332.00 |
DisclosureSEC source: 0001035267-24-000275 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,506 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 18:48 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 188 | $290.33 | $54,582.04 |
DisclosureSEC source: 0001035267-24-000275 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 22:42 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 198 | $0.00 Strike: $347.42 | $0.00 |
DisclosureSEC source: 0001035267-24-000269 · edgardoc.xml · derivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 597 Underlying: Common Stock · 198 shares Expires 2031-08-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 22:42 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 198 | $0.00 Strike: $245.60 | $0.00 |
DisclosureSEC source: 0001035267-24-000269 · edgardoc.xml · derivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 597 Underlying: Common Stock · 198 shares Expires 2031-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 22:42 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 198 | $542.06 | $107,327.88 |
DisclosureSEC source: 0001035267-24-000269 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,506 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 22:42 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 198 | $245.60 | $48,628.80 |
DisclosureSEC source: 0001035267-24-000269 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 22:42 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 198 | $542.06 | $107,327.88 |
DisclosureSEC source: 0001035267-24-000269 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,506 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 22:42 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 198 | $347.42 | $68,788.51 |
DisclosureSEC source: 0001035267-24-000269 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 23:03 UTC |
Samath JamieCFO and Head of Business Techn
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 54 | $0.00 Strike: $347.42 | $0.00 |
DisclosureSEC source: 0001035267-24-000271 · edgardoc.xml · derivative · entry 6 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 159 Underlying: Common Stock · 54 shares Expires 2031-08-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 23:03 UTC |
Samath JamieCFO and Head of Business Techn
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 54 | $0.00 Strike: $245.60 | $0.00 |
DisclosureSEC source: 0001035267-24-000271 · edgardoc.xml · derivative · entry 5 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 159 Underlying: Common Stock · 54 shares Expires 2031-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 23:03 UTC |
Samath JamieCFO and Head of Business Techn
|
SaleCommon Stock | 54 | $542.06 | $29,271.24 |
DisclosureSEC source: 0001035267-24-000271 · edgardoc.xml · nonDerivative · entry 4 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,757 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 23:03 UTC |
Samath JamieCFO and Head of Business Techn
|
Exercise / conversionCommon Stock | 54 | $245.60 | $13,262.40 |
DisclosureSEC source: 0001035267-24-000271 · edgardoc.xml · nonDerivative · entry 3 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 23:03 UTC |
Samath JamieCFO and Head of Business Techn
|
SaleCommon Stock | 54 | $542.06 | $29,271.24 |
DisclosureSEC source: 0001035267-24-000271 · edgardoc.xml · nonDerivative · entry 2 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,757 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 23:03 UTC |
Samath JamieCFO and Head of Business Techn
|
Exercise / conversionCommon Stock | 54 | $347.42 | $18,760.50 |
DisclosureSEC source: 0001035267-24-000271 · edgardoc.xml · nonDerivative · entry 1 Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
| November 22, 2024 Filed Nov 22, 2024 20:56 UTC |
Rosa David J.President
|
GiftCommon Stock | 915 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-24-000267 · edgardoc.xml · nonDerivative · entry 1 Rosa David J. · CIK 0001519593 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,080 F1 · kind: The filer gifted shares to The Rosa Donor Advised Fund. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,199 | $0.00 Strike: $229.39 | $0.00 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · derivative · entry 12 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,829 Underlying: Common Stock · 2,199 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. F5 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,010 | $0.00 Strike: $208.90 | $0.00 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · derivative · entry 11 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,005 Underlying: Common Stock · 4,010 shares Expires 2029-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $182.83 | $0.00 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · derivative · entry 10 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2029-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,257 | $0.00 Strike: $177.99 | $0.00 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · derivative · entry 9 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,257 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 4,010 | $535.96 | $2,149,187.17 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 8 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 298 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 4,010 | $208.90 | $837,689.00 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 7 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 2,199 | $535.96 | $1,178,569.22 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 6 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 298 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 2,199 | $229.39 | $504,428.61 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 5 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 5,000 | $535.96 | $2,679,784.50 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 4 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 298 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $182.83 | $914,166.50 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 3 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 2,257 | $535.96 | $1,209,654.72 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 2 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 298 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:21 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 2,257 | $177.99 | $401,715.98 |
DisclosureSEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 1 Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 18:34 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 120 | $0.00 Strike: $304.67 | $0.00 |
DisclosureSEC source: 0001035267-24-000261 · edgardoc.xml · derivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,232 Underlying: Common Stock · 120 shares Expires 2030-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F3 · derivative.exercise_date: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 18:34 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 119 | $0.00 Strike: $229.39 | $0.00 |
DisclosureSEC source: 0001035267-24-000261 · edgardoc.xml · derivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,233 Underlying: Common Stock · 119 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. F2 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 18:34 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 119 | $539.89 | $64,246.91 |
DisclosureSEC source: 0001035267-24-000261 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,506 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 18:34 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 119 | $229.39 | $27,297.41 |
DisclosureSEC source: 0001035267-24-000261 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 18:34 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
SaleCommon Stock | 120 | $539.89 | $64,786.80 |
DisclosureSEC source: 0001035267-24-000261 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,506 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 18:34 UTC |
DeSantis RobertEVP & Chief Strategy & Corp Op
|
Exercise / conversionCommon Stock | 120 | $304.67 | $36,560.40 |
DisclosureSEC source: 0001035267-24-000261 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 00:16 UTC |
Samath JamieSee Remarks
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 134 | $0.00 Strike: $304.67 | $0.00 |
DisclosureSEC source: 0001610717-24-000519 · form4.xml · derivative · entry 30 Samath Jamie · CIK 0001330269 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,636 Underlying: Common Stock · 134 shares Expires 2030-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. F6 · derivative.exercise_date: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 00:16 UTC |
Samath JamieSee Remarks
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 135 | $0.00 Strike: $229.39 | $0.00 |
DisclosureSEC source: 0001610717-24-000519 · form4.xml · derivative · entry 29 Samath Jamie · CIK 0001330269 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,636 Underlying: Common Stock · 135 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. F5 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 00:16 UTC |
Samath JamieSee Remarks
|
SaleCommon Stock | 269 | $539.89 | $145,230.41 |
DisclosureSEC source: 0001610717-24-000519 · form4.xml · nonDerivative · entry 16 Samath Jamie · CIK 0001330269 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,757 F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.